Botox 200 UNT Injection

DRUG4 trials

Sponsors

Vanderbilt University Medical Center, University of Alberta, University of Gaziantep, Danish Headache Center

Conditions

Botulinum Toxins, Type ACarotid Dissection ArteryCerebral Venous Sinus ThrombosisDiabetes Mellitus, Type 2Headache, MigraineHemorrhagic StrokeNeurogenic Bladder DisorderObese

Phase 1

Investigating Effects of BOTOX on Weight Loss and Glucose Tolerance in Obese, Type 2 Diabetic Subjects

TerminatedNCT03991299

Vanderbilt University Medical CenterDiabetes Mellitus, Type 2, Obese

Start: 2021-04-29End: 2022-02-11Updated: 2023-02-28

Onabotulinum Toxin A (Botox) for the Treatment of Persistent Post-Stroke and Vascular Headache

WithdrawnNCT04580238

University of AlbertaBotulinum Toxins, Type A, Carotid Dissection Artery, Cerebral Venous Sinus Thrombosis +5

Start: 2023-12-31End: 2025-06-30Updated: 2024-09-19

Phase 3

Safety and Efficacy of Botulinum Toxin A in Patients With Posttraumatic Headache

RecruitingNCT06839118

Danish Headache CenterPosttraumatic Headache

Start: 2025-01-10End: 2026-08-01Target: 80Updated: 2025-02-21

Unknown Phase

Predictive Urodynamic Parameters for The Treatment Efficacy of Onabotulinum A Toxin in Neurogenic Lower Urinary Tract Dysfunction

CompletedNCT06485453

University of GaziantepNeurogenic Bladder Disorder

Start: 2013-09-01End: 2024-06-01Updated: 2024-07-03